Preferential transduction of neurons by canine adenovirus vectors and their efficient retrograde transport in vivo
- 17 August 2001
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 15 (12) , 1-23
- https://doi.org/10.1096/fj.01-0321fje
Abstract
In the central nervous system (CNS), there are innate obstacles to the modification of neurons: their relative low abundance versus glia and oligodendrocytes, the inaccessibility of certain target populations, and the volume one can inject safely. Our aim in this study was to characterize the in vivo efficacy of a novel viral vector derived from a canine adenovirus (CAV-2). Here we show that CAV-2 preferentially transduced i) rat olfactory sensory neurons; ii) rodent CNS neurons in vitro and in vivo; and, more clinically relevant, iii) neurons in organotypic slices of human cortical brain. CAV-2 also showed a high disposition for retrograde axonal transport in vivo. We examined the molecular basis of neuronal targeting by CAV-2 and suggest that due to CAR (coxsackie adenovirus receptor) expression on neuronal cells-and not oligodendrocytes, glia, myofibers, and nasal epithelial cells-CAV-2 vectors transduced neurons preferentially in these diverse tissues.Keywords
This publication has 72 references indexed in Scilit:
- Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous systemProceedings of the National Academy of Sciences, 2000
- Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in ratsProceedings of the National Academy of Sciences, 1997
- A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signalProceedings of the National Academy of Sciences, 1996
- A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.Proceedings of the National Academy of Sciences, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.Proceedings of the National Academy of Sciences, 1990
- Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vectorGene, 1989
- A Defective HSV-1 Vector Expresses Escherichia coli β-Galactosidase in Cultured Peripheral NeuronsScience, 1988
- Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.Proceedings of the National Academy of Sciences, 1984